Cryo-Cell International, Inc.
Cryo-Cell International, Inc. (CCEL) is a Medical care facilities company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Cryo-Cell International, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
- Sector
- Healthcare
- Industry
- Medical care facilities
- Country
- United States
- Exchange
- New York Stock Exchange
- CEO
- David I. Portnoy
- Employees
- 82
- IPO date
- 04 Apr 1994
- ISIN
- US2288951088
- Website
- cryo-cell.com
Frequently asked questions
Where is Cryo-Cell International, Inc. stock listed?
Cryo-Cell International, Inc. (CCEL) is listed on New York Stock Exchange.